The 5 Most Interesting Analyst Questions From ANI Pharmaceuticals's Q3 Earnings Call [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
strong momentum across its Rare Disease and Generics segments. CEO Nikhil Lalwani highlighted that Cortrophin Gel nearly doubled net revenue compared to the prior year and that a significant partner generic launch further bolstered results. The company also saw record new patient starts and expanded prescriber adoption, especially in new therapeutic areas such as pulmonology and ophthalmology. Lalwani pointed to “the strong underlying demand and the addressable patient populations across key indications” as core drivers behind the quarter's success. Is now the time to buy ANIP? Find out in our full research report (it's free for active Edge members). ANI Pharmaceuticals (ANIP) Q3 CY2025 Highlights: Revenue: $227.8 million vs analyst estimates of $214.1 million (53.6% year-on-year growth, 6.4% beat) Adjusted EPS: $2.04 vs analyst estimates of $1.77 (15.2% beat) Adjusted EBITDA: $59.6 million vs analyst estimates of $55.24 million (26.2% margin, 7.9% beat) The company lifted
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina FranchiseGlobeNewswire
- ANI Pharmaceuticals Announces Board TransitionGlobeNewswire
- Does Recent Pipeline News Signal a New Opportunity for ANI Pharmaceuticals Stock in 2025? [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
ANIP
Earnings
- 11/7/25 - Beat
ANIP
Sec Filings
- 12/1/25 - Form 8-K
- 11/17/25 - Form 4
- 11/14/25 - Form 4
- ANIP's page on the SEC website